Cleared Traditional

K021813 - HYDROCISION GENERAL SURGERY FLUIDJET SYSTEM (FDA 510(k) Clearance)

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K021813 · Hydrocision, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2003
Decision
340d
Days
Class 2
Risk

K021813 is an FDA 510(k) clearance for the HYDROCISION GENERAL SURGERY FLUIDJET SYSTEM. Classified as Lavage, Jet (product code FQH), Class II - Special Controls.

Submitted by Hydrocision, Inc. (Hopkonton, US). The FDA issued a Cleared decision on May 9, 2003 after a review of 340 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5475 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Hydrocision, Inc. devices

Submission Details

510(k) Number K021813 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 03, 2002
Decision Date May 09, 2003
Days to Decision 340 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
212d slower than avg
Panel avg: 128d · This submission: 340d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FQH Lavage, Jet
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5475
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FQH Lavage, Jet

All 52
Devices cleared under the same product code (FQH) and FDA review panel - the closest regulatory comparables to K021813.
BD Surgiphor™ Antimicrobial Irrigation System (910110)
K253996 · Becton, Dickinson and Company (BD) · Feb 2026
BD Surgiphor™ 1000 mL Antimicrobial Irrigation System (910120)
K253445 · Bd · Feb 2026
ERBEJET® 2 System
K231023 · Erbe Elektromedizin GmbH · Jun 2023
Armis VeriCyn Wound Wash
K220759 · Armis Biopharma, Inc. · May 2023
VERSAJET Hydrosurgery System (III)
K220964 · Smith & Nephew Medical Limited · May 2023
BD Surgiphor™ Antimicrobial Irrigation System
K221504 · Bd · Oct 2022